Getinge AB (publ) GNGBF Stock
Getinge AB (publ) Price Chart
Getinge AB (publ) GNGBF Financial and Trading Overview
| Getinge AB (publ) stock price | 20.05 USD |
| Previous Close | 20.05 USD |
| Open | 20.05 USD |
| Bid | 19.76 USD x 10000 |
| Ask | 21.7 USD x 30000 |
| Day's Range | 20.05 - 20.05 USD |
| 52 Week Range | 18.82 - 24.75 USD |
| Volume | 100 USD |
| Avg. Volume | 1 USD |
| Market Cap | 5.46B USD |
| Beta (5Y Monthly) | 0.783 |
| PE Ratio (TTM) | 21.55914 |
| EPS (TTM) | 0.93 USD |
| Forward Dividend & Yield | 0.52 (2.57%) |
| Ex-Dividend Date | April 22, 2026 |
| 1y Target Est | N/A |
GNGBF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | 21.55914 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 1.48 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.187182 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Getinge AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.783 |
| 52-Week Change | -5.021% |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 24.75 USD |
| 52 Week Low | 18.82 USD |
| 50-Day Moving Average | 22.28 USD |
| 200-Day Moving Average | 22.14 USD |
GNGBF Share Statistics
| Avg. Volume (3 month) | 1 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 254.15M |
| Float | 178.53M |
| Short Ratio | N/A |
| % Held by Insiders | 15.75% |
| % Held by Institutions | 68.14% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 166.00% |
| Payout Ratio | 0.5312 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 6.91% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 47.41% |
| EBITDA Margin | 16.02% |
Management Effectiveness
| Return on Assets (ttm) | 4.56% |
| Return on Equity (ttm) | 7.68% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -10.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | 5.46B USD |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.93 |
| Quarterly Earnings Growth (yoy) | 33.70% |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 35.4 USD |
| Current Ratio (mrq) | 1.349 |
| Book Value Per Share (mrq) | 107.115 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | 2.92B USD |
Profile of Getinge AB (publ)
| Country | United States |
| State | N/A |
| City | Gothenburg |
| Address | Lindholmspiren 7A |
| ZIP | 417 56 |
| Phone | 46 1 03 35 00 00 |
| Website | https://www.getinge.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 11754 |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
Q&A For Getinge AB (publ) Stock
What is a current GNGBF stock price?
Getinge AB (publ) GNGBF stock price today per share is 20.05 USD.
How to purchase Getinge AB (publ) stock?
You can buy GNGBF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Getinge AB (publ)?
The stock symbol or ticker of Getinge AB (publ) is GNGBF.
Which industry does the Getinge AB (publ) company belong to?
The Getinge AB (publ) industry is Medical Devices.
How many shares does Getinge AB (publ) have in circulation?
The max supply of Getinge AB (publ) shares is 272.37M.
What is Getinge AB (publ) Price to Earnings Ratio (PE Ratio)?
Getinge AB (publ) PE Ratio is 21.55914000 now.
What was Getinge AB (publ) earnings per share over the trailing 12 months (TTM)?
Getinge AB (publ) EPS is 0.93 USD over the trailing 12 months.
Which sector does the Getinge AB (publ) company belong to?
The Getinge AB (publ) sector is Healthcare.


